FindTrial
Sign In

Clinical application of His-Purkinje system pacing technique

Prospective evaluation of clinical safety and efficacy of left bundle branch area pacing in comparison with right ventricular sepal pacing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046901
Enrollment
Unknown
Registered
2021-05-30
Start date
2019-02-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arhythmia

Interventions

LBBaP group:LBBaP
RVSP group:RVSP

Sponsors

Xiangtan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
43 Years to 84 Years

Inclusion criteria

Inclusion criteria: This study was performed in Xiangtan Central Hospital with consecutive pacemaker-indicated patients who received LBBaP or RVSP from February 2019 to May 2020, according to 2013 ESC/EHRA Guidelines on cardiac pacing.

Exclusion criteria

Exclusion criteria: 1. previously implanted with cardiac devices; 2. underwent cardiac resynchronization therapy (CRT); 3. moderate to severe valvular diseases; 4. acute or old myocardial infarction; 5. severe liver, kidney or lung dysfunction.

Design outcomes

Primary

MeasureTime frame
QRS duration;left ventricular ejection fraction (LVEF);left ventricular end-diastolic diameter (LVEDD);interventricular mechanical delay (IVMD);septal-posterior wall motion delay (SPWMD);pacing parameters;complications;—

Secondary

MeasureTime frame
operation time;Radiation dose;stimulus to peak left ventricular activation time (S-PLVAT);—

Countries

China

Contacts

Public ContactWu mingxing

Department of Cardiology, Xiangtan Central Hospital

wmx8977@126.com+86 13973258977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026